BUY CREDITACCESS GRAMEEN LIMITED — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)17 May 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·17 Sept · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on CREDITACCESS GRAMEEN
- BUY — Sudeep Shah, SBICAP Securities11 Sept 2026 · ~2 weeks · target ₹1,500 · SL hit
- BUY — Motilal Oswal25 Aug 2026 · ~1 year · target ₹1,880 · Active
- BUY — Sudeep Shah, SBICAP Securities13 Aug 2026 · ~2 weeks · target ₹1,700 · SL hit
- BUY — Rakesh Bansal12 Aug 2026 · ~3 months · target ₹1,650 · Active
- BUY — Kavita Jain, Arihant Capital Markets31 Jul 2026 · ~2 weeks · target ₹1,670 · SL hit
More from Motilal Oswal
- BUY Emcure Pharmaceuticals21 Oct 2026 · ~1 year · target ₹2,330 · Active
- BUY Aditya Birla Sun Life AMC21 Oct 2026 · ~1 year · target ₹1,160 · Active
- BUY Mahindra & Mahindra Financial Services21 Oct 2026 · ~1 year · target ₹375 · Active
- BUY Hindalco Industries21 Oct 2026 · ~1 year · target ₹1,170 · Active
- BUY Eternal21 Oct 2026 · ~1 year · target ₹420 · Active

